These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
221 related items for PubMed ID: 18834575
1. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Chee SP, Jap A, Bacsal K. Am J Ophthalmol; 2009 Jan; 147(1):154-161.e1. PubMed ID: 18834575 [Abstract] [Full Text] [Related]
2. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Lai TY, Chan RP, Chan CK, Lam DS. Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377 [Abstract] [Full Text] [Related]
3. Vogt-Koyanagi-Harada disease in children. Abu El-Asrar AM, Al-Kharashi AS, Aldibhi H, Al-Fraykh H, Kangave D. Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116 [Abstract] [Full Text] [Related]
4. Vogt-Koyanagi-Harada disease in Thai patients. Tesavibul N, Sansanayuth W. J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S26-30. PubMed ID: 16681048 [Abstract] [Full Text] [Related]
5. Risk factors for poor visual outcome following cataract surgery in Vogt-Koyanagi-Harada disease. Quek DT, Jap A, Chee SP. Br J Ophthalmol; 2011 Nov; 95(11):1542-6. PubMed ID: 21349937 [Abstract] [Full Text] [Related]
6. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Read RW, Yu F, Accorinti M, Bodaghi B, Chee SP, Fardeau C, Goto H, Holland GN, Kawashima H, Kojima E, Lehoang P, Lemaitre C, Okada AA, Pivetti-Pezzi P, Secchi A, See RF, Tabbara KF, Usui M, Rao NA. Am J Ophthalmol; 2006 Jul; 142(1):119-24. PubMed ID: 16815259 [Abstract] [Full Text] [Related]
7. Vogt-Koyanagi-Harada disease: clinical outcomes. Bykhovskaya I, Thorne JE, Kempen JH, Dunn JP, Jabs DA. Am J Ophthalmol; 2005 Oct; 140(4):674-8. PubMed ID: 16226518 [Abstract] [Full Text] [Related]
8. Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease. Guo YL, Du Y, He JF. Am J Ophthalmol; 2009 May; 147(5):946; author reply 946-7. PubMed ID: 19376333 [No Abstract] [Full Text] [Related]
9. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease. Chee SP, Jap A. Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203 [Abstract] [Full Text] [Related]
16. Vogt-Koyanagi-Harada disease in Thailand. Yodmuang T, Rothova A, Kunavisarut P, Pathanapitoon K. Ocul Immunol Inflamm; 2012 Dec; 20(6):419-22. PubMed ID: 23163754 [Abstract] [Full Text] [Related]
17. Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease. Urzua CA, Velasquez V, Sabat P, Berger O, Ramirez S, Goecke A, Vásquez DH, Gatica H, Guerrero J. Acta Ophthalmol; 2015 Sep; 93(6):e475-80. PubMed ID: 25565265 [Abstract] [Full Text] [Related]
18. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Paredes I, Ahmed M, Foster CS. Ocul Immunol Inflamm; 2006 Apr; 14(2):87-90. PubMed ID: 16597537 [Abstract] [Full Text] [Related]
19. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease. Fang W, Zhou H, Yang P, Huang X, Wang L, Kijlstra A. Br J Ophthalmol; 2008 Feb; 92(2):182-5. PubMed ID: 17965105 [Abstract] [Full Text] [Related]